Travere Therapeutics
TVTX
TVTX
126 hedge funds and large institutions have $1.09B invested in Travere Therapeutics in 2015 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 40 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
48% more capital invested
Capital invested by funds: $735M → $1.09B (+$356M)
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
Holders
126
Holding in Top 10
8
Calls
$45.5M
Puts
$6.75M
Top Buyers
| 1 | +$30.8M | |
| 2 | +$11M | |
| 3 | +$10.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.5M |
| 5 |
CCM
Consonance Capital Management
New York
|
+$9.7M |
Top Sellers
| 1 | -$26.5M | |
| 2 | -$20.6M | |
| 3 | -$15.6M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$10.8M |
| 5 |
Jennison Associates
New York
|
-$9.16M |